Proprotein Convertase Subtilisin-Kexin Type 9 inhibitors and stroke prevention: A meta-analysis
DSpace/Manakin Repository
Proprotein Convertase Subtilisin-Kexin Type 9 inhibitors and stroke prevention: A meta-analysis
Sagris, Dimitrios; Ntaios, George; Georgiopoulos, Georgios; Pateras, Konstantinos; Milionis, Haralampos
(2021) European journal of internal medicine, volume 85, issue 3, pp. 130 - 132
(Comment)
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
Keywords: Alirocumab, Evolocumab, Lipid-lowering, PCSK9 inhibitor, Statin, Stroke, Internal Medicine
DOI:
https://doi.org/10.1016/j.ejim.2020.11.021
ISSN: 0953-6205
Publisher: Elsevier
Note: Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
(Peer reviewed)